STOCK TITAN

Vikas Mehta sells 25,000 RELY shares via 10b5-1 (NASDAQ: RELY)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Vikas Mehta reported a proposed sale of 25,000 shares of Common Stock on a Form 144.

The filing lists 25,000 Restricted Stock Units dated 08/25/2025 and records a 10b5-1 sale of 25,000 shares on 03/03/2026 for $437,500. Broker listed: Morgan Stanley Smith Barney LLC.

Positive

  • None.

Negative

  • None.

Insights

Routine officer/director resale under a 10b5-1 plan; transaction appears procedural.

The filing shows a proposed sale notice for 25,000 shares and an executed 10b5-1 sale of $437,500 on 03/03/2026. This is a common disclosure when restricted shares or RSUs are sold through broker arrangements.

Timing and cashflow treatment are set by the selling arrangement; subsequent filings will show final disposition details if warrants, withholding or additional sales occur.

Proposed sale 25,000 shares Form 144 proposed sale listed
10b5-1 sale proceeds $437,500 Sale executed on 03/03/2026
10b5-1 sale shares 25,000 shares Sale executed on 03/03/2026
RSUs listed 25,000 RSUs Restricted Stock Units dated 08/25/2025
Shares outstanding (excerpt) 210,561,079 shares listed with date 05/26/2026
Restricted Stock Units financial
"Restricted Stock Units | Issuer | 25000 | 08/25/2025"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
10b5-1 regulatory
"10b5-1 Sales for VIKAS MEHTA | Common | 03/03/2026"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did the Form 144 for RELY disclose about the transaction?

The Form 144 discloses a proposed sale of 25,000 common shares by Vikas Mehta, lists 25,000 RSUs dated 08/25/2025, and records a 10b5-1 sale on 03/03/2026 that generated $437,500.

Who executed the sale and through which broker was it placed?

The sale was executed under a 10b5-1 plan for Vikas Mehta and placed through Morgan Stanley Smith Barney LLC. The filing names the broker and shows the trade details for the reported transactions on the dates provided.

How many shares and what proceeds are shown in the filing?

The filing shows a proposed sale of 25,000 shares and a disclosed 10b5-1 sale of 25,000 shares for $437,500. Both share counts and the sale proceeds are listed in the provided excerpt.

Do the documents indicate whether the sale was pre‑arranged under a trading plan?

Yes. The filing specifically references a 10b5-1 sale on 03/03/2026, indicating the transaction was executed under a pre-arranged trading plan rather than an ad hoc open-market decision.